Training for health professionals

For the past four years Boyes Turner has held a free annual Mesothelioma and Lung Cancer Study Day at our offices at Abbots House, Abbey Street in Reading.

We extend an open invitation to all those involved in the fields of mesothelioma and lung cancer to attend our study days which are accredited by the Royal College of Physicians and the Royal College of Nursing.

We have been very fortunate to enjoy some excellent presentations in the past, including Professor Loic Lang-Lazdunski, a Professor in thoracic surgery, who discussed the current research and trials in mesothelioma. We have also had Dr Peter Szlosarek, a Clinical Senior Lecturer and Honorary Consultant in medical oncology, discussing oncology research in mesothelioma and the recent Adam trial results. In 2014 Eric Lim, a Consultant Thoracic Surgeon, was able to bring us up-to-date with the current mesothelioma clinical trials including MARS II. Consultant Lung Cancer Nurses, Anne Moylan and Naomi Horne, both of whom work on behalf of the charity Mesothelioma UK, also attended to discuss the role of the lung cancer nurse and Mesothelioma UK.

Our 5th annual Mesothelioma and Lung Cancer Study Day will take place on 13 September 2018 at our Reading offices. The speakers are:

• Mr John Pilling, Consultant Thoracic Surgeon, Guy's and St Thomas' NHS Foundation Trust
   
• Natasha Bruce-Jones, Senior Occupational Therapist, Plexus Healthcare
   
• Dr Jeremy Steele,  Consultant Oncologist, Barts and the London NHS Trust
   
• Harry Steinberg QC, Barrister, 12 Kings Bench Walk
   
• Simon Bolton, Mesothelioma UK and Lung Cancer Nurse Specialist, Harrogate and District NHS Trust
   
• Mesothelioma UK representative
• Laura Magson, Senior associate - solicitor, Boyes Turner

More information to follow. To book your place click here.

The study day is aimed at nurses, doctors, consultants and all other medical professionals who treat and care for, or have an interest in the treatment and care of, people with mesothelioma and lung cancer.